Clopidogrel and atorvastatin - Significant drug-drug interactions are seen

被引：0
|
作者：
不详
机构：
来源：
AMERICAN JOURNAL OF NURSING | 2003年 / 103卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
引用
收藏
页码：56GG / 56HH
页数：2
相关论文
共 50 条
  • [11] Impact of Genetic Polymorphisms and Drug-Drug Interactions on Clopidogrel and Prasugrel Response Variability
    Ancrenaz, V.
    Daali, Y.
    Fontana, P.
    Besson, M.
    Samer, C.
    Dayer, P.
    Desmeules, J.
    CURRENT DRUG METABOLISM, 2010, 11 (08) : 667 - 677
  • [12] DRUG-DRUG INTERACTIONS
    FORTH, W
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1976, 26 (NA1): : 108 - 114
  • [13] Clinically Significant Psychotropic Drug-Drug Interactions in the Primary Care Setting
    Brett A. English
    Marcus Dortch
    Larry Ereshefsky
    Stanford Jhee
    Current Psychiatry Reports, 2012, 14 : 376 - 390
  • [14] COMPUTERIZED DETECTION SYSTEM FOR POTENTIALLY SIGNIFICANT ADVERSE DRUG-DRUG INTERACTIONS
    FORD, DR
    RIVERS, NP
    WOOD, GC
    JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION, 1977, 17 (06): : 354 - 357
  • [15] Clinically Significant Psychotropic Drug-Drug Interactions in the Primary Care Setting
    English, Brett A.
    Dortch, Marcus
    Ereshefsky, Larry
    Jhee, Stanford
    CURRENT PSYCHIATRY REPORTS, 2012, 14 (04) : 376 - 390
  • [16] Drug-drug interactions
    Preskorn, SH
    JOURNAL OF CLINICAL PSYCHIATRY, 1996, 57 (05) : 223 - 225
  • [17] No clinically relevant drug-drug interactions when dalcetrapib is co-administered with atorvastatin
    Derks, Michael
    Abt, Markus
    Parr, Graeme
    Meneses-Lorente, Georgina
    Young, Anne-Marie
    Phelan, Mary
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2010, 19 (10) : 1135 - 1145
  • [18] Evaluation of Luteolin Nanosuspensions on Pharmacokinetics of Atorvastatin: Drug-Drug Interactions Using Rat Models
    Liang, You
    Sun, Bo
    Yang, Min
    Meng, Xiaona
    Wang, Meng
    Yang, Lijuan
    AI-Hamyari, Bandar
    Zhang, Yuqian
    Shen, Yutong
    Meng, Shengnan
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2025, 20 : 2557 - 2573
  • [19] Physiologically based pharmacokinetic modeling of disposition and drug-drug interactions for atorvastatin and its metabolites
    Zhang, Tao
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 77 : 216 - 229
  • [20] COMPARING THE VALUE OF EVIDENCE OVER TIME FOR CLOPIDOGREL PHARMACOGENOMICS VERSUS DRUG-DRUG INTERACTIONS
    Guzauskas, G. F.
    Serbin, M.
    Veenstra, D. L.
    VALUE IN HEALTH, 2016, 19 (03) : A54 - A54
12345